Forte Common Stock vs Retained Earnings Analysis
FBRX Stock | USD 0.72 0.02 2.70% |
Forte Biosciences financial indicator trend analysis is much more than just examining Forte Biosciences latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Forte Biosciences is a good investment. Please check the relationship between Forte Biosciences Common Stock and its Retained Earnings accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
Common Stock vs Retained Earnings
Common Stock vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Forte Biosciences Common Stock account and Retained Earnings. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Forte Biosciences' Common Stock and Retained Earnings is -0.47. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Forte Biosciences, assuming nothing else is changed. The correlation between historical values of Forte Biosciences' Common Stock and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Forte Biosciences are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Common Stock i.e., Forte Biosciences' Common Stock and Retained Earnings go up and down completely randomly.
Correlation Coefficient | -0.47 |
Relationship Direction | Negative |
Relationship Strength | Very Weak |
Common Stock
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Forte Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Forte Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.Selling General Administrative is likely to drop to about 10.1 K in 2024. Tax Provision is likely to drop to 855.00 in 2024
2023 | 2024 (projected) | Depreciation And Amortization | 9K | 8.6K | Interest Income | 1.1M | 1.3M |
Forte Biosciences fundamental ratios Correlations
Click cells to compare fundamentals
Forte Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Forte Biosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.7M | 61.2M | 43.3M | 42.0M | 39.0M | 43.2M | |
Other Current Liab | 343.2K | 1.0M | 812K | 2.0M | 2.2M | 4.0M | |
Total Current Liabilities | 1.9M | 2.3M | 1.8M | 3.2M | 3.7M | 6.0M | |
Total Stockholder Equity | (4.8M) | 59.0M | 41.5M | 38.8M | 35.3M | 42.2M | |
Property Plant And Equipment Net | 4.0M | 150.6K | 97K | 0.0 | 109K | 103.6K | |
Net Debt | 1.8M | (58.8M) | (42.0M) | (41.1M) | (12.0M) | (12.6M) | |
Retained Earnings | (5.0M) | (51.5M) | (73.2M) | (87.0M) | (118.5M) | (124.4M) | |
Accounts Payable | 1.6M | 1.2M | 946K | 1.2M | 1.4M | 1.3M | |
Cash | 6.9M | 58.8M | 42.0M | 41.1M | 12.0M | 11.4M | |
Non Current Assets Total | 150.6K | 1.3M | 786K | 486K | 653.0K | 620.3K | |
Other Assets | 227K | 1.4M | 0.0 | 1.0 | 0.9 | 0.86 | |
Cash And Short Term Investments | 6.9M | 58.8M | 42.0M | 41.1M | 37.1M | 41.0M | |
Common Stock Total Equity | 20K | 23K | 1K | 13K | 11.7K | 9.9K | |
Common Stock Shares Outstanding | 2.1M | 7.4M | 14.0M | 17.4M | 31.6M | 33.1M | |
Short Term Investments | 52.8M | 55.3M | 12.8M | 25.2M | 22.6M | 29.7M | |
Liabilities And Stockholders Equity | 7.7M | 61.2M | 43.3M | 42.0M | 39.0M | 43.2M | |
Non Current Liabilities Total | 28.4M | 10.5M | 1.2M | 946K | 1.2M | 0.0 | |
Other Current Assets | 53.2K | 76K | 88K | 70K | 1.2M | 672.5K | |
Other Stockholder Equity | (10.3M) | 110.4M | 114.7M | 125.8M | 153.8M | 105.4M | |
Total Liab | 12.4M | 2.3M | 1.8M | 3.2M | 3.7M | 3.5M | |
Property Plant And Equipment Gross | 4.0M | 150.6K | 97K | 0.0 | 118K | 112.1K | |
Total Current Assets | 7.5M | 59.9M | 42.5M | 41.5M | 38.3M | 41.8M | |
Accumulated Other Comprehensive Income | 10K | (61.2M) | (43.3M) | 4K | 3.6K | 3.8K | |
Common Stock | 23K | 1K | 13K | 21K | 36K | 37.8K | |
Property Plant Equipment | 1.2M | 4.0M | 152K | 97K | 87.3K | 82.9K | |
Net Tangible Assets | (4.8M) | 59.0M | 41.5M | 38.8M | 44.6M | 29.4M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Forte Biosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Forte Stock analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is Forte Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.00) | Return On Assets (0.50) | Return On Equity (0.85) |
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.